Arix Bioscience plc (ARIX.L) LSE

142.00

-1.5(-1.05%)

Updated at February 09, 2024 05:15PM

Currency In GBp

Arix Bioscience plc

Address

Duke Street House

London, W1K 6JL

United Kingdom of Great Britain and Northern Ireland

Phone

44 20 7290 1050

Sector

Healthcare

Industry

Biotechnology

Employees

9

First IPO Date

February 17, 2017

Key Executives

NameTitlePayYear Born
Tassos KonstantinouManaging Director0N/A
Felix BreyerAssociate0N/A
Roy Bartel-TavernerAnalyst0N/A
Tom DavidsonChief Operating Officer & Chief Financial Officer0N/A
Jade FletcherFinancial Controller0N/A
Laura CraigInvestor Relations Officer0N/A

Description

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.